BIO 06 — Aging in Women: The Menopausal Transition
Course Format: On campus
Duration: 5 weeks
Date(s): Oct 6—Nov 3
Time: 7:00—8:50 pm
Drop Deadline: Oct 19
Unit(s): 1 Units
Oct 6—Nov 3
Menopause is a scientific enigma that will affect every woman in the world. Presently, approximately 48 million women in the United States have entered the menopause transition, and many women can spend up to one-third of their lifetime in menopause. Although researchers and studies have implicated a decline in estrogen levels with the onset of menopause, the exact biological mechanism of menopause’s action remains unknown. After the controversial Women’s Health Initiative study (2002) linked hormone replacement therapy (HRT) to cancer, what was once a $4 billion market dominated by HRT lacked any viable menopause-specific therapeutics. In this course, we will explore the current research and theories that attempt to explain the evolution and biology of menopause, as well as the therapeutic avenues currently being explored. As we explore the unique biology of aging in women we will also hear guest lectures from experts and innovators who are attempting to redefine menopause and who have identified unique populations, including women with the Fragile X mutation and women who have undergone IVF and have early-onset menopause.
Sohila Zadran, Founder, Igantia TherapeuticsSohila Zadran is the founder of Igantia Therapeutics, a research organization focused on developing technologies to better understand and treat menopause. She received a PhD in neuroscience from USC and was a postdoctoral fellow in systems neuroscience at the California Institute of Technology.
Textbooks for this course:
(Recommended) Christa De Souza, The Hot Topic: The Life Changing Look at the Change in Life (ISBN 978-1780722672)